Dental and Medical Problems

Dent Med Probl
Index Copernicus (ICV 2020) – 128.41
MEiN – 70 pts
CiteScore (2021) – 2.0
JCI – 0.5
Average rejection rate (2021) – 81.35%
ISSN 1644-387X (print)
ISSN 2300-9020 (online)
Periodicity – quarterly

Download PDF

Dental and Medical Problems

2019, vol. 56, nr 3, July-September, p. 317–321

doi: 10.17219/dmp/108632

Publication type: clinical case

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

Low-level laser therapy (LLLT) in the treatment of recurrent aphthous stomatitis (RAS) – a promising treatment option: A report of two cases

Terapia laserem małej mocy w aftach nawrotowych – obiecująca opcja w leczeniu. Opis dwóch przypadków

Maria Olejnik1,A,B,C,D, Zuzanna Ślebioda1,B,C,D, Barbara Dorocka-Bobkowska1,A,E,F

1 Department of Gerodontology and Oral Pathology, Poznan University of Medical Sciences, Poland

Abstract

Recurrent aphthous stomatitis (RAS) is a chronic, ulcerative condition of the oral mucosa that affects 10–25% of the population. The etiopathogenesis of the disease is not fully understood, although a polygenic mode of inheritance and immunological dysregulation have been suggested in several studies. The contribution of numerous predisposing factors, such as a deficiency of iron, vitamin B12 or folic acid, trauma, emotional stress, endocrine disturbances, or allergy, have also been considered. So far, no causative treatment for RAS has been developed; instead, topical and systemic drugs are used to reduce pain and inflammation, and to lengthen the period of remission. Low-level laser therapy (LLLT) is a non-invasive and atraumatic therapeutic method that involves the local application of a high-density, monochromatic, narrow-band light source. With the use of the appropriate power and wavelength, the therapy brings anti-inflammatory and analgesic results, and wound healing is promoted. Several reports on the beneficial effects of LLLT in RAS have been presented recently. This report describes 2 cases of adult patients with RAS treated with LLLT to relieve pain and promote the healing of the ulcers. The clinical presentations with the signs and symptoms are discussed and illustrated, along with the treatment algorithms and outcomes.

Key words

oral mucosa, low-level laser therapy, aphthous stomatitis

Słowa kluczowe

błona śluzowa jamy ustnej, terapia laserem małej mocy, aftowe zapalenie jamy ustnej

References (30)

  1. Belenguer-Guallar I, Jiménez-Soriano Y, Claramunt-Lozano A. Treatment of recurrent aphthous stomatitis. A literature review. J Clin Exp Dent. 2014;6(2):e168–e174.
  2. Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dent Clin North Am. 2014;58(2):281–297.
  3. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: A consensus approach. J Am Dent Assoc. 2003;134(2):200–206.
  4. Ślebioda Z, Szponar E, Kowalska A. Etiopathogenesis of recurrent aphthous stomatitis and the role of immunologic aspects: Literature review. Arch Immunol Ther Exp (Warsz). 2014;62(3):205–215.
  5. Ślebioda Z, Kowalska A, Rozmiarek M, Krawiecka E, Szponar E, Dorocka-Bobkowska B. The absence of an association between interleukin 1ß gene polymorphisms and recurrent aphthous stomatitis (RAS). Arch Oral Biol. 2017;84:45–49.
  6. Al-Samadi A, Salem A, Ainola M, Hietanen J, Häyrinen-Immonen R, Konttinen YT. Increased beta 2 defensin in recurrent aphthous ulcer. Oral Dis. 2015;21(3):292–298.
  7. Davies A, Gebremedhin S, Yee M, et al. Cationic porphyrin-mediated photodynamic inactivation of Candida biofilms and the effect of miconazole. J Physiol Pharmacol. 2016;67(5):777–783.
  8. Dorocka-Bobkowska B, Düzgüneş N, Konopka K. AmBisome and Amphotericin B inhibit the initial adherence of Candida albicans to human epithelial cell lines, but do not cause yeast detachment. Med Sci Monit. 2009;15(9):BR262–BR269.
  9. Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M. Recurrent aphthous stomatitis. Quintessence Int. 2000;31(2):95–112.
  10. Guimarães AL, Correia-Silva Jde F, Sá AR, et al. Investigation of functional gene polymorphisms IL-1beta, IL-6, IL-10 and TNF-alpha in individuals with recurrent aphthous stomatitis. Arch Oral Biol. 2007;52(3):268–272.
  11. Ślebioda Z, Szponar E, Kowalska A. Defensins and their role in the maintenance of the oral cavity homeostasis – a literature review. Centr Eur J Immunol. 2013;38(1):111–117.
  12. Tarakji B, Gazal G, Al-Maweri SA, Azzeghaiby SN, Al Aizari NA. Guideline for the diagnosis and treatment of recurrent aphthous stomatitis for dental practitioners. J Int Oral Health. 2015;7(5):74–80.
  13. Barrons RW. Treatment strategies for recurrent oral aphthous ulcers. Am J Health Syst Pharm. 2001;58(1):41–50.
  14. Iwanicka-Grzegorek E, Puczyłowska-Rybaczyk M. Therapeutic and diagnostic application of laser in oral cavity diseases [in Polish]. Nowa Stomat. 2011;16(3):128–133.
  15. Cotler HB, Chow RT, Hamblin MR, Carroll J. The use of low level laser therapy (LLLT) for musculoskeletal pain. MOJ Orthop Rheumatol. 2015;2(5):00068.
  16. Owczarek B, Kiernicka M, Gałkowska E, Wysokińska-Miszczuk J. Influence of laser biostimulation on the healing of tissues in patients treated for chronic periodontitis [in Polish]. Dent Med Probl. 2004;41(1):45–49.
  17. Hall G, Anneroth G, Schennings T, Zetterqvist L, Rydén H. Effect of low level energy laser irradiation on wound healing. An experimental study in rats. Swed Dent J. 1994;18(1–2):29–34.
  18. Caputo BV, Noro-Filho GA, dos Santos CC, Okida Y, Giovani EM. Laser therapy of recurrent aphthous ulcer in patient with HIV infection. Case Rep Med. 2012;2012:695642.
  19. Albrektson M, Hedström L, Bergh H. Recurrent aphthous stomatitis and pain management with low-level laser therapy: A randomized controlled trial. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(5):590–594.
  20. Aggarwal H, Singh MP, Nahar P, Mathur H, Gv S. Efficacy of low-level laser therapy in treatment of recurrent aphthous ulcers – a sham-controlled, split mouth follow up study. J Clin Diagn Res. 2014;8(2):218–221.
  21. Al Mulla F, Al Amari R, Zakaria D, Hemdan H. Diode laser treatment in aphthous ulcer for handicapped patients in Kuwait. J Am Sci. 2012;8(8):994–997.
  22. Khademi H, Shirami AM, Nikegbal F. Evaluation of low level laser therapy in recurrent aphthous stomatitis. Shiraz Univ Dent J. 2009;10(2):160–162.
  23. De Souza TO, Martins MA, Bussadori SK, et al. Clinical evaluation of low-level laser treatment for recurring aphthous stomatitis. Photomed Laser Surg. 2010;28(Suppl 2):S85–S88.
  24. Anand V, Gulati M, Govila V, Anand B. Low level laser therapy in the treatment of aphthous ulcer. Indian J Dent Res. 2013;24(2):267–270.
  25. Gandhi Babu DB, Chavva S, Waghray S, Jyothi Allam NS, Kondaiah M. Low level laser therapy to reduce recurrent oral ulcers in Behçet’s disease. Case Rep Dent. 2016;2016:4283986.
  26. Lalabonova H, Daskalov H. Clinical assessment of the therapeutic effect of low-level laser therapy on chronic recurrent aphthous stomatitis. Biotechnol Biotechnol Equip. 2014;28(5):929–933.
  27. Jijin MJ, Rakaraddi M, Pai J, et al. Low-level laser therapy versus 5% amlexanox: A comparison of treatment effects in a cohort of patients with minor aphthous ulcers. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121(3):269–273.
  28. Kashmoola MA, Salman H, Al-Waez MM. Clinical effect of low level laser therapy on healing of recurrent aphthous ulcer and oral ulcera­tion in Behcet’s disease. J Coll Dent. 2005;17(2):36–40.
  29. Arabaci T, Kara C, Ciçek Y. Relationship between periodontal parameters and Behçet’s disease and evaluation of different treatments for oral recurrent aphthous stomatitis. J Periodontal Res. 2009;44(6):718–725.
  30. Tezel A, Kara C, Balkaya V, Orbak R. An evaluation of different treatments for recurrent aphthous stomatitis and patient perceptions: Nd:YAG laser versus medication. Photomed Laser Surg. 2009;27(1):101–106.